TNF-α depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment.

[1]  T. Vanden Berghe,et al.  RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. , 2011, Immunity.

[2]  N. Rifai,et al.  Standardization of high-sensitivity immunoassays for measurement of C-reactive protein; II: Two approaches for assessing commutability of a reference material. , 2009, Clinical chemistry.

[3]  I. J. Iizuka,et al.  The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury , 2008, Critical care medicine.

[4]  P. Peduzzi,et al.  Intensity of renal support in critically ill patients with acute kidney injury. , 2008, The New England journal of medicine.

[5]  C. Schmid,et al.  Evaluation of the modification of diet in renal disease study equation in a large diverse population. , 2007, Journal of the American Society of Nephrology : JASN.

[6]  R. Bellomo,et al.  Patient and Kidney Survival by Dialysis Modality in Critically Ill Patients with Acute Kidney Injury , 2007 .

[7]  C. Ronco.  Continuous dialysis is superior to intermittent dialysis in acute kidney injury of the critically ill patient , 2007, Nature Clinical Practice Nephrology.

[8]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[9]  D. Sit,et al.  The Evaluation of Effects of Demographic Features, Biochemical Parameters, and Cytokines on Clinical Outcomes in Patients with Acute Renal Failure , 2007, Renal failure.

[10]  S. Uchino,et al.  The epidemiology of acute renal failure in the world , 2006, Current opinion in critical care.

[11]  Jonathan Himmelfarb,et al.  Survival by dialysis modality in critically ill patients with acute kidney injury. , 2006, Journal of the American Society of Nephrology : JASN.

[12]  Emil,et al.  Plasma cytokine levels predict mortality in patients with acute renal failure. , 2004, Kidney international.

[13]  M. Netea,et al.  Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? , 2003, Trends in immunology.

[14]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[15]  J. le Gall,et al.  Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients* , 2002, Critical care medicine.

[16]  R. Bellomo,et al.  Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia , 2001, Critical care medicine.

[17]  P. Kimmel,et al.  Biocompatibility of Hemodialysis Membranes: Interrelations between Plasma Complement and Cytokine Levels , 2001, Blood Purification.

[18]  R. Kaplan,et al.  A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. , 2001, Kidney international.

[19]  Shigeaki Kobayashi,et al.  Predictors of Mortality in Patients Treated with Continuous Hemodiafiltration for Acute Renal Failure in an Intensive Care Setting , 2001, ASAIO journal.

[20]  Rinaldo Bellomo,et al.  Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial , 2000, The Lancet.

[21]  C. Sprung,et al.  Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score , 2000, Intensive Care Medicine.

[22]  L. Zampedri,et al.  Prognosis in acute renal failure of septic origin: a multivariate analysis. , 1998, Renal failure.

[23]  J Pascual,et al.  The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. , 1998, Kidney international. Supplement.

[24]  B. Jaber,et al.  Inflammatory mediators in sepsis: rationale for extracorporeal therapies? , 1996 .

[25]  Paul Landais,et al.  Acute renal failure in intensive care units : causes, outcome, and prognostic factors of hospital mortality : a prospective, multicenter study , 1996 .

[26]  P. Ferdinande,et al.  Removal of pro-inflammatory cytokines with renal replacement therapy: Sense or nonsense? , 1995, Intensive Care Medicine.

[27]  S. Goldfarb,et al.  Proinflammatory cytokines and hemofiltration membranes. , 1994, Journal of the American Society of Nephrology : JASN.

[28]  R. Zatz,et al.  Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. , 1994, The American journal of physiology.

[29]  J. Wetzels,et al.  Removal of interleukin-1 beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes. , 1992, Lymphokine and cytokine research.

[30]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[31]  P. Tarli,et al.  Simplified enzymic/colorimetric serum urea nitrogen determination. , 1979, Clinical chemistry.

[32]  J. H. Stein,et al.  Disorders of hypo- and hyperkalemia. , 1977, Clinical nephrology.

[33]  M J Lysaght,et al.  Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow-fiber blood ultrafilter. , 1975, The Journal of laboratory and clinical medicine.

[34]  Daniela Germin Petrović.  [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis]. , 2004, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[35]  H. Bruining,et al.  Cytokine Kinetics (TNF-α, IL-1β, IL-6) during Continuous Hemofiltration: A Laboratory and Clinical Study , 1995 .

[36]  M. Jaffé,et al.  Ueber den Niederschlag, welchen Pikrinsäure in normalem Harn erzeugt und über eine neue Reaction des Kreatinins. , 1886 .